About BLAAC PD
BLAAC PD is a research study. It collects information on health, disease, and genes to learn more about Parkinson's.
BLAAC PD is happening at sites around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of Parkinson's genetics.
What are genes?
Genes are passed on from parents, and some gene changes may raise the risk of disease.
Other studies have found connections between genes and Parkinson's. That has led to new treatments in testing to fix the effects of gene changes. But those results have mostly come from studies with non-Black or African American volunteers.
BLAAC PD aims to fill in research gaps
BLAAC PD aims to learn more about gene changes that may cause Parkinson’s in Black and African American people.
This new data could lead to future Parkinson’s tests and treatments for Black and African American people. And it may help better understand disease in other groups too.
Joining the study
BLAAC PD needs people with and without Parkinson's disease.
You can join if you:
- Are Black or African American
- Are aged 18 or older
- Have been diagnosed with Parkinson's OR
- Do not have PD and do not have a parent, sibling, or child with PD
Joining a research study is your choice. The study team can talk with you more about what it means to join BLAAC PD.
Study Details:
- Attend only one visit
- Give under one hour of your time
- Give either a blood or saliva sample
- Answer questions about your health and family history
- You may also have a brief physical exam
- You will not be given a study drug
- We will compensate you for your participation
There is no cost to join this study. Your health insurance will not be charged.
Your Privacy
Your privacy is very important. The study has put measures in place to safeguard the information you contribute. The study team can talk more about these measures and your privacy.
BLAAC PD and GP2 share their data with scientists to look for discoveries that could lead to new treatments. Those partners must agree to also protect your privacy.